Johnson & Johnson's McNeil Consumer Healthcare unit has awarded consumer PR duties for some of its Tylenol product lines to Zeno Group, following an RFP process.
The McNeil operation has endured a series of recalls since 2010 -- most recently in September -- that tarnished the trusted images of McNeil and J&J, which has responded with executive and supply chain changes.
J&J told O'Dwyer's that Zeno's consumer PR savvy will be a "complimentary addition to the ongoing work we do with other agency partners supporting Tylenol and other brands within our OTC business."
Barbara Montresor, former VP of corporate communications for McNeil, moved to J&J's Vision Care operation last year. J&J also created a "corporate equity" post in the wake of the recalls to focus repairing its reputation. Longtime J&J communications executive Sarah Colamarino has served as VP in that role.
Zeno's consumer healthcare experience includes AstraZeneca, Lung Cancer Research Foundation and Bausch + Lomb. Ame Wadler heads the firm's healthcare operation.